Overview
Detlev Ganten (born 1941) is a specialist in pharmacology and molecular medicine and is one of the leading scientists in the field of hypertension. He founded the World Health Summit in 2009. He was Chairman of the Foundation Board of the Charité Foundation (2005–2015), editor of the Journal of Molecular Medicine (since 1993), Chairman of the Board of Trustees of the Max Planck Institute of Colloids and Interfaces and Max Planck Institute of Molecular Plant Physiology as well as Chairman of the Board of Trustees of the Ethnological Museum Dahlem of the Prussian Cultural Heritage Foundation.
From 2004 to 2008, he was CEO of the Charité – Universitätsmedizin Berlin. and from 1991 to 2004 Founding Director and CEO of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association.
Academic and professional career
Ganten was born in Lüneburg. He completed agricultural training in Elmshorn in 1959 with the agricultural assistant state examination. Following his secondary education he studied medicine in Würzburg and Montpellier from 1962 to 1964 and worked in the surgical ward of the hospital "La Mamounia" in Marrakesh. From 1966 to 1968 he continued his medical studies in Tübingen, concluding them with the medical state examination and subsequent internships in Tübingen and Emden. In 1968 Ganten received his MD from the University of Tübingen followed by a research period (1969 to 1973) at the Clinical Research Institute in Montreal affiliated with the University of Montreal. In 1970 he received his license to practice medicine and then in 1973, obtained the degree of Doctor of Philosophy (PhD) from McGill University in Montreal.
From 1973 to 1991 Ganten worked for the Pharmacological Institute of the University of Heidelberg where he also qualified as a professor in 1974. In 1975 he received a professorship in Pharmacology at the Medical Faculty of Heidelberg University. In 1978 he became specialist in Pharmacology and Clinical Pharmacology.
From Wikipedia (CC BY-SA 4.0).